New cure strategies for Hepatitis B are in development. Emerging data suggests a key role for biomarkers to identify subsets of people living with Hepatitis B who are most likely to respond to treatment. In this webinar, we discussed recent advances in Hepatitis B biomarker development, and how these tools can be used to personalise the management of people living with Hepatitis B.
 

Поделитесь этим:

Другие материалы по этой же теме

Select a related post from the options below.

Рекомендуемые темы

СеквенированиеКРАСНЫЙ 2020Редкие заболевания
Читать далее
Scroll to Top